Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis - Wikidata - wikimedia - TriplyDB

Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis

Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis

http://www.wikidata.org/entity/Q35872096

about

Molecular mechanism of hepatitis B virus X protein function in hepatocarcinogenesis Clinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: a meta-analysis The dual role of the novel Wnt receptor tyrosine kinase, ROR2, in human carcinogenesis Expression of Wnt-5a and β-catenin in primary hepatocellular carcinoma.Up-regulation of ROR2 is associated with unfavorable prognosis and tumor progression in cervical cancer Cytoplasmic and/or nuclear expression of β-catenin correlate with poor prognosis and unfavorable clinicopathological factors in hepatocellular carcinoma: a meta-analysis.Downregulation of KIF1B mRNA in hepatocellular carcinoma tissues correlates with poor prognosis.WNT5A inhibits hepatocyte proliferation and concludes β-catenin signaling in liver regeneration.Inactivation of the WNT5A Alternative Promoter B Is Associated with DNA Methylation and Histone Modification in Osteosarcoma Cell Lines U2OS and SaOS-2 Knockdown of receptor tyrosine kinase-like orphan receptor 2 inhibits cell proliferation and colony formation in osteosarcoma cells by inducing arrest in cell cycle progression.Over-expression of ROR2 and Wnt5a cooperatively correlates with unfavorable prognosis in patients with non-small cell lung cancer.Targeting ROR1 inhibits epithelial-mesenchymal transition and metastasis.ROR2 inhibits the proliferation of gastric carcinoma cells via activation of non-canonical Wnt signaling.Wnt5a involved in regulation of the biological behavior of hepatocellular carcinoma.Carboxyl-terminal truncated HBx contributes to invasion and metastasis via deregulating metastasis suppressors in hepatocellular carcinoma.Ectopic repression of receptor tyrosine kinase-like orphan receptor 2 inhibits malignant transformation of ovarian cancer cells by reversing epithelial-mesenchymal transition.Validation of specificity of antibodies for immunohistochemistry: the case of ROR2.Epigenetic identification of receptor tyrosine kinase-like orphan receptor 2 as a functional tumor suppressor inhibiting β-catenin and AKT signaling but frequently methylated in common carcinomas.High expression levels of Wnt5a and Ror2 in laryngeal squamous cell carcinoma are associated with poor prognosis Association between Wnt inhibitory factor 1 and receptor tyrosine kinase-like orphan receptor 2 protein expression and the clinical pathological significance in benign and malignant pancreatic lesions.Prognostic significance of Ror2 and Wnt5a expression in medulloblastoma.Chromosomal abnormalities in hepatic cysts point to novel polycystic liver disease genes.The clinical pathological significance of FRAT1 and ROR2 expression in cartilage tumors.Role of WNT5A receptors FZD5 and RYK in prostate cancer cells.

P2860

Q26782044-9FF9EA5B-F022-4A28-92A3-FFDAEFBE37E7 Q26784351-DDD5E1B7-9249-4FA6-AFFE-E9D9ED9362E9 Q26829919-28379002-64B9-4808-87F3-5388E79DF24C Q33898617-21EDC543-935F-49CF-84B4-FE83EC99F63C Q35145060-9E4BF937-0907-4DC3-8D01-8282A708405C Q35424206-5CAE2DA7-F814-48A3-98DB-237316C76567 Q35865284-DC79A67F-37DD-4DAC-9051-81D806BDF612 Q35931831-45C632D5-B156-4EEA-A4DF-75381CD972C3 Q35957843-E771A932-0DB6-422E-B821-CA757E18DD94 Q36335326-4D63E4F2-48FE-41B9-B854-096216CE7A0B Q36413067-375550A3-6B10-4EFE-B1B4-E8DC35F57A69 Q37320359-4A58A296-2D40-42A6-87A0-81A3B7B6B8E9 Q37581948-E02EBEA5-1815-4376-BF65-BBD1450892A6 Q37676740-950DB3A7-7C63-48F7-8DF8-F12A41F7905E Q37688204-36723BCD-31BF-428F-BFA0-CEE8CF2AA31A Q38704722-68878CE3-609E-4848-BF15-B710FCC4817A Q38800075-DB550FE7-7E38-4836-B00C-9D04D61AFE90 Q39070771-8C9FE3D7-7BC6-4E41-AA9D-4E8D4C0C514B Q41145048-8A13171E-CEA2-4A5B-BC70-122F3F730674 Q42290641-8D788736-C609-44D7-B7BD-8463266B5BFA Q45052680-2BC0FC3D-9C75-49E7-B065-143A7C3C583B Q47137161-CD2897F7-F764-4924-A13C-30CBDD8F3147 Q54310279-7ABDC0FA-8F43-4F6A-BEEB-557F44BAFC39 Q55332428-0E2109CA-37AF-4585-87B4-B29280D13A88

P2860

Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis

http://www.wikidata.org/entity/Q35872096

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis

@ast

Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis

@en

type

label

Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis

@ast

Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis

@en

prefLabel

Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis

@ast

Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis

@en

P1433

Q35872096-130860B9-3152-4F29-A749-A792B0999D9A

P1476

Q35872096-D1887381-10CA-4D8D-B6A6-0F3431D3DFE2

P2093

Q35872096-4B5DC9E3-CF87-4629-8888-EB30BD47E99A

Q35872096-57F812EC-83D6-496F-A98B-DABED665DB12

Q35872096-7553624B-87C5-4FFA-8D08-7BC11A672C52

Q35872096-A2EC02DF-DFFE-480F-AC6F-806ACE1430B1

Q35872096-B58C6911-C488-4CAE-B189-A44A28FA79BA

Q35872096-BBFB9B34-43BE-4C14-A2CF-1B839675CA43

P2860

Q35872096-0137015D-3748-413E-8260-FC956849687E

Q35872096-0DC60CBF-8A83-442C-8A05-DF1D22EBB165

Q35872096-1FD4252D-3AD1-4567-B060-1069223F74A6

Q35872096-24829BF5-CEDB-4511-B2EC-761E7ADDC621

Q35872096-2E80091F-3B98-4A13-862B-286B4D6B24FD

Q35872096-30D7A051-45EC-4A00-8883-DEB1FC3B4BE2

Q35872096-3AB1344E-9AC4-4B84-981F-5A5235D9918C

Q35872096-44E081C1-D674-45DD-A433-0B94DB2787E6

Q35872096-45C048D6-190F-4C32-BC01-C55E26E54776

Q35872096-48741E0F-FF72-4667-9BCE-07E8948B60C2

P304

Q35872096-9972DD84-5EB2-491B-A3B0-B8B5CB802568

P31

Q35872096-C14E4195-013B-4880-85CF-C068EC3F302A

P356

Q35872096-D0B604AF-68F9-4B6E-BBC8-ACC03973355E

P407

Q35872096-70CEA651-E46D-421D-9EFC-CD67DD5E7A90

P433

Q35872096-4F26C427-7D51-4B17-B1B7-875F116FDECB

P478

Q35872096-6EACAA93-AF6F-4250-A2E4-1EFE91FEE596

P577

Q35872096-916EBB72-01EA-4431-B94B-31B6252A20DA

P5875

Q35872096-F72E866C-3775-4CA3-BC53-E83272C1D9C0

P698

Q35872096-61D968D9-FBB3-444A-9C8F-45ACCD92DA08

P932

Q35872096-53914DDC-27C3-4C48-BB67-003DDD6842FD

P356

WJG.V18.I12.1328

P1433

World Journal of Gastroenterology

P1476

Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis

@en

P2093

Hui Jiang

http://www.w3.org/2001/XMLSchema#string

Li-Quan Bi

http://www.w3.org/2001/XMLSchema#string

Ming Geng

http://www.w3.org/2001/XMLSchema#string

Xiao-Hong Liu

http://www.w3.org/2001/XMLSchema#string

Ying-Jian Chen

http://www.w3.org/2001/XMLSchema#string

Yong-Cheng Cao

http://www.w3.org/2001/XMLSchema#string

P2860

Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma

Two members of the Tcf family implicated in Wnt/beta-catenin signaling during embryogenesis in the mouse.

Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation

The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/beta-catenin signaling.

Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma

The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma

Intercellular adhesion, signalling and the cytoskeleton

Wnt-5a has tumor suppressor activity in thyroid carcinoma

Ror2 receptor requires tyrosine kinase activity to mediate Wnt5A signaling

Post-translational palmitoylation and glycosylation of Wnt-5a are necessary for its signalling

P304

1328-1338

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V18.I12.1328

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223974905

http://www.w3.org/2001/XMLSchema#string

P698

22493546

http://www.w3.org/2001/XMLSchema#string

P932

3319959

http://www.w3.org/2001/XMLSchema#string